Lichen Nitidus Treatment Market Information: By Type (Topical, Oral), By Treatment (Corticosteroids, Retinoid, Antihistamines, Phototherapy, Others), By End Users (Hospitals, Dermatology Clinics, Others) - Global Forecast Till 2027Market HighlightsPrevalence of skin diseases is increasing across the globe.
People are unaware of most of the rare skin diseases.
The market for lichen nitidus treatment is driven by growing prevalence of this disease in both developed and developing countries.
There has been an increase in the geriatric population suffering from skin disease, which remain untreated for a long period of time.
The global lichen nitidus treatment market is expected to grow at a CAGR of 8.7% during the forecast period and is estimated to reach USD 170 million by 2023.Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report.
(U.K), AstraZeneca (U.K), Hubei Gedian Humanwell Pharmaceutical Co.,Ltd (China), Farmabios SPA (Italy), Horizon Pharma plc.